HemostOD closes a CHF 4.3M funding round to continue developing their ex vivo, donor-free, off-the-shelf universal human blood platelets October 6, 2025
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform April 29, 2025
The very first VITAL Biotech Accelerator Cohort has been selected, promoted by BARDA December 16, 2024
